Nordic Consortium for Acute Type a Aortic Dissection-2

Launched by KAROLINSKA INSTITUTET · Mar 3, 2025

Keywords

ClinConnect Summary

The Nordic Consortium for Acute Type A Aortic Dissection-2 (NORCAAD-2) is a large research study that aims to gather important information about a serious condition called acute type A aortic dissection (ATAAD). This condition is a medical emergency where the inner layer of the aorta, the large blood vessel that carries blood from the heart, tears. The study involves multiple hospitals across Nordic countries and the Netherlands, and it focuses on collecting detailed information about patients who experience this condition. Researchers want to understand more about the risk factors, the procedures used to treat patients, and the outcomes, including any complications and survival rates over time.

To participate in this trial, individuals must be adults aged 18 or older who have been diagnosed with acute type A aortic dissection within 14 days of the onset of symptoms. Participants can expect to contribute to a better understanding of ATAAD, which may help improve treatment strategies in the future. This study is currently recruiting patients, and it aims to gather as much data as possible to identify ways to enhance patient care and reduce complications related to this life-threatening condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Acute (within 14 days of onset) type A aortic dissection or similar acute aortic syndrome
• Exclusion Criteria:
• • Age \<18 years at onset